Opiant Pharmaceuticals Inc.

NAS: OPNT

GO
/marketstate/country/us

Market open

/zigman2/quotes/205337064/composite

$

26.00

Change

-1.00 -3.70%

Volume

Volume 28,416

Jan 27, 2022, 12:40 p.m.

Real time quotes

/zigman2/quotes/205337064/composite

Previous close

$ 27.00

$ 26.00

Change

-1.00 -3.70%

Day low

Day high

$25.58

$27.95

Open
Open: 27.14

52 week low

52 week high

$10.00

$37.71

Open

Market cap

$127.45M

Average volume

68,096

P/E ratio

542.27

Rev. per Employee

$1.46M

EPS

0.05

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/opnt

MarketWatch News on OPNT

  1. Opiant Pharmaceuticals started at outperform with $42 stock price target at Oppenheimer

    7:51 a.m. Dec. 9, 2021

    - Tomi Kilgore

  2. Opiant, Sanofi to make cannabinoid overdose drug

    9:16 a.m. Dec. 26, 2018

    - MarketWatch.com

  3. Opnet Shrs Swoon; Trims June Quarter Revenue Guidance

    7:21 p.m. May 5, 2017

    - Barrons Blogs

/news/nonmarketwatch/company/us/opnt

Other News on OPNT

  1. 10-Q: OPIANT PHARMACEUTICALS, INC.

    8:09 a.m. Nov. 12, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  2. Opiant Pharmaceuticals EPS beats by $0.35, beats on revenue

    4:05 p.m. Nov. 11, 2021

    - Seeking Alpha

  3. Opiant Pharmaceuticals Q3 2021 Earnings Preview

    5:35 p.m. Nov. 10, 2021

    - Seeking Alpha

  4. Notable earnings after Thursday's close

    5:35 p.m. Nov. 10, 2021

    - Seeking Alpha

  5. Opiant Pharmaceuticals: Assessing Recent Insider Buying

    8:06 a.m. Sept. 19, 2021

    - Seeking Alpha

  6. 10-Q: OPIANT PHARMACEUTICALS, INC.

    3:23 p.m. Aug. 5, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  7. IP, BTU, ONCS among pre market gainers

    7:28 a.m. July 8, 2021

    - Seeking Alpha

  8. BTU, ONCS, DARE among mid-day movers

    12:22 p.m. July 7, 2021

    - Seeking Alpha

  9. CLOV, CRNT among premarket gainers

    7:15 a.m. July 7, 2021

    - Seeking Alpha

  10. Opiant shares rise on OPNT003 opioid overdose study results

    3:05 p.m. July 6, 2021

    - Seeking Alpha

  11. 10-Q: OPIANT PHARMACEUTICALS, INC.

    3:12 p.m. May 11, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  12. Opiant Pharmaceuticals starts dosing in OPNT003 study

    3:16 p.m. April 5, 2021

    - Seeking Alpha

  13. Opiant Pharmaceuticals awarded final tranche of NIDA grant

    3:06 p.m. March 31, 2021

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/opnt

Press Releases on OPNT

  1. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.